Total Payments
$7,778
2024 Payments
$1,676
Companies
42
Transactions
425
Medicare Patients
2,075
Medicare Billing
$168,052
Payment Breakdown by Category
Food & Beverage$7,733 (99.4%)
Education$45.15 (0.6%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,733 | 420 | 99.4% |
| Education | $45.15 | 5 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,819 | 94 | $0 (2024) |
| PFIZER INC. | $797.04 | 52 | $0 (2024) |
| Lilly USA, LLC | $751.73 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $543.86 | 25 | $0 (2024) |
| ABBVIE INC. | $531.05 | 22 | $0 (2024) |
| Amgen Inc. | $443.49 | 28 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $411.67 | 22 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $299.21 | 17 | $0 (2024) |
| Lundbeck LLC | $251.61 | 16 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $243.45 | 14 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,676 | 83 | Novo Nordisk Inc ($334.06) |
| 2023 | $1,761 | 85 | Novo Nordisk Inc ($294.98) |
| 2022 | $1,259 | 61 | Novo Nordisk Inc ($390.82) |
| 2021 | $733.70 | 41 | Novo Nordisk Inc ($231.74) |
| 2020 | $353.37 | 20 | Novo Nordisk Inc ($117.47) |
| 2019 | $648.10 | 42 | Novo Nordisk Inc ($197.60) |
| 2018 | $783.91 | 54 | Novo Nordisk Inc ($170.31) |
| 2017 | $562.95 | 39 | Allergan Inc. ($97.32) |
All Payment Transactions
425 individual payment records from CMS Open Payments — Page 3 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: Diabetes | ||||||
| 04/26/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9, VAQTA | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: VACCINE | ||||||
| 04/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Diabetes | ||||||
| 04/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: Biological | ||||||
| 04/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: Oncology | ||||||
| 04/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: Respiratory | ||||||
| 04/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Diabetes | ||||||
| 04/04/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $31.00 | General |
| Category: VACCINES | ||||||
| 04/01/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: NEUROSCIENCE | ||||||
| 03/19/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: PAIN | ||||||
| 03/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.93 | General |
| 03/15/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $7.22 | General |
| Category: VACCINES | ||||||
| 03/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: NEUROSCIENCE | ||||||
| 03/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.90 | General |
| Category: PSYCHIATRY | ||||||
| 02/27/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Diabetes | ||||||
| 02/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: RESPIRATORY | ||||||
| 02/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $28.69 | General |
| Category: Diabetes | ||||||
| 02/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Diabetes | ||||||
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Respiratory | ||||||
| 02/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Gastroenterology | ||||||
| 02/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: VACCINES | ||||||
| 02/02/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: Biological | ||||||
| 01/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.82 | General |
| Category: PSYCHIATRY | ||||||
| 01/24/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $0.45 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 385 | 635 | $94,471 | $31,383 |
| 2022 | 13 | 490 | 831 | $89,659 | $37,343 |
| 2021 | 15 | 625 | 1,140 | $129,447 | $53,300 |
| 2020 | 17 | 575 | 1,028 | $117,360 | $46,027 |
Total Patients
2,075
Total Services
3,634
Medicare Billing
$168,052
Procedure Codes
57
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 62 | 121 | $34,940 | $9,765 | 27.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 27 | 27 | $19,143 | $7,638 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 44 | 77 | $16,976 | $4,764 | 28.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 29 | 29 | $5,191 | $2,198 | 42.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $3,930 | $1,766 | 44.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 12 | 23 | $4,244 | $1,448 | 34.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 35 | 35 | $2,537 | $1,138 | 44.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 27 | 27 | $1,971 | $877.50 | 44.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 47 | 88 | $2,176 | $837.76 | 38.5% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 50 | 138 | $1,650 | $442.98 | 26.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 26 | 43 | $705.00 | $361.20 | 51.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 14 | $1,008 | $147.00 | 14.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 71 | 145 | $32,595 | $13,532 | 41.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 63 | 111 | $18,058 | $7,057 | 39.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 35 | 35 | $9,625 | $4,882 | 50.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 37 | 38 | $3,398 | $2,662 | 78.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 20 | 41 | $6,667 | $2,427 | 36.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 15 | $4,425 | $1,687 | 38.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 47 | 48 | $2,640 | $1,536 | 58.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 53 | 109 | $2,834 | $1,038 | 36.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 14 | 15 | $2,475 | $901.28 | 36.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 13 | 15 | $2,100 | $685.05 | 32.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 54 | 170 | $2,890 | $548.89 | 19.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 56 | 76 | $912.00 | $225.27 | 24.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 13 | $1,040 | $160.26 | 15.4% |
About Dr. Mark Belsky, MD
Dr. Mark Belsky, MD is a Family Medicine healthcare provider based in Hartford, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548284474.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Belsky, MD has received a total of $7,778 in payments from pharmaceutical and medical device companies, with $1,676 received in 2024. These payments were reported across 425 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($7,733).
As a Medicare-enrolled provider, Belsky has provided services to 2,075 Medicare beneficiaries, totaling 3,634 services with total Medicare billing of $168,052. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Hartford, CT
- Active Since 07/26/2006
- Last Updated 06/21/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1548284474
Products in Payments
- Ozempic (Drug) $653.67
- MOUNJARO (Drug) $527.92
- Rybelsus (Drug) $432.10
- XIFAXAN (Drug) $411.67
- ELIQUIS (Drug) $281.17
- UBRELVY (Drug) $281.09
- REXULTI (Drug) $251.61
- SHINGRIX (Biological) $232.53
- TRELEGY ELLIPTA (Drug) $206.25
- VRAYLAR (Drug) $188.00
- TRULICITY (Drug) $183.62
- CHANTIX (Drug) $178.63
- PREVNAR 20 (Biological) $167.51
- Veozah (Drug) $152.07
- Prolia (Biological) $150.66
- Tresiba (Drug) $143.42
- XARELTO (Drug) $127.12
- BREZTRI (Drug) $124.74
- Victoza (Drug) $121.67
- Otezla (Drug) $119.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Hartford
Mohammad Samer Younes, M.d, M.D
Family Medicine — Payments: $16,845
Family Medicine $16,845
Dr. Nieves Hornbeck, M.d, M.D
Family Medicine — Payments: $7,619
Family Medicine $7,619
Charlecinth Roberts, Md, MD
Family Medicine — Payments: $7,389
Family Medicine $7,389
Susan Wiskowski, Md, MD
Family Medicine — Payments: $4,449
Family Medicine $4,449
Sama Alvi, M.d, M.D
Family Medicine — Payments: $4,362
Family Medicine $4,362
Ms. Magilta Joseph, Msm Aprn Fnp-Bc, MSM APRN FNP-BC
Family Medicine — Payments: $2,876
Family Medicine $2,876